Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Alcorn

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Current Opinion in Immunology|February 28, 2015
The immunology of influenza virus-associated bacterial pneumoniaKeven M Robinson, Jay K Kolls, John F Alcorn
Clinical Science (London, England : 1979)|July 11, 2020
Influenza sequelae: from immune modulation to persistent alveolitisEllyse M Cipolla, Brydie R Huckestein, John F Alcorn
Annual Review of Physiology|February 13, 2010
TH17 cells in asthma and COPDJohn F Alcorn, Christopher R Crowe, Jay K Kolls
Clinical Microbiology Reviews|May 31, 2019
Host-Pathogen Interactions in Gram-Positive Bacterial PneumoniaJennifer A Grousd, Helen E Rich, John F Alcorn
BMC Bioinformatics|June 5, 2019
A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discoveryEmily E Ackerman, John F Alcorn, Takeshi Hase, et al.
Current Allergy and Asthma Reports|June 14, 2013
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disordersKeven M Robinson, Michelle L Manni, Partha S Biswas, et al.
American Journal of Respiratory Cell and Molecular Biology|March 26, 2003
Pseudomonas aeruginosa elastase degrades surfactant proteins A and DWilliam I Mariencheck, John F Alcorn, Scott M Palmer, et al.
Frontiers in Immunology|October 26, 2020
Insights Into Type I and III Interferons in Asthma and ExacerbationsHelen E Rich, Danielle Antos, Natalie R Melton, et al.
Plos One|December 11, 2013
A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severityKevin J McHugh, Sivanarayana Mandalapu, Jay K Kolls, et al.
The American Journal of Pathology|August 15, 2012
The receptor for advanced glycation end products is a central mediator of asthma pathogenesisPavle S Milutinovic, John F Alcorn, Judson M Englert, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Current Opinion in Immunology|February 28, 2015
The immunology of influenza virus-associated bacterial pneumoniaKeven M Robinson, Jay K Kolls, John F Alcorn
Clinical Science (London, England : 1979)|July 11, 2020
Influenza sequelae: from immune modulation to persistent alveolitisEllyse M Cipolla, Brydie R Huckestein, John F Alcorn
Annual Review of Physiology|February 13, 2010
TH17 cells in asthma and COPDJohn F Alcorn, Christopher R Crowe, Jay K Kolls
Clinical Microbiology Reviews|May 31, 2019
Host-Pathogen Interactions in Gram-Positive Bacterial PneumoniaJennifer A Grousd, Helen E Rich, John F Alcorn
BMC Bioinformatics|June 5, 2019
A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discoveryEmily E Ackerman, John F Alcorn, Takeshi Hase, et al.
Current Allergy and Asthma Reports|June 14, 2013
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disordersKeven M Robinson, Michelle L Manni, Partha S Biswas, et al.
American Journal of Respiratory Cell and Molecular Biology|March 26, 2003
Pseudomonas aeruginosa elastase degrades surfactant proteins A and DWilliam I Mariencheck, John F Alcorn, Scott M Palmer, et al.
Frontiers in Immunology|October 26, 2020
Insights Into Type I and III Interferons in Asthma and ExacerbationsHelen E Rich, Danielle Antos, Natalie R Melton, et al.
Plos One|December 11, 2013
A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severityKevin J McHugh, Sivanarayana Mandalapu, Jay K Kolls, et al.
The American Journal of Pathology|August 15, 2012
The receptor for advanced glycation end products is a central mediator of asthma pathogenesisPavle S Milutinovic, John F Alcorn, Judson M Englert, et al.
Pageof 15